Brandinium

Trademark search for:

LAYPEX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-07-06 — Application filed
  • 2016-08-25 — Sn assigned for sect 66a subseq desig from ib
  • 2016-08-26 — Application filed
  • 2016-09-06 — Assigned to examiner
  • 2016-09-06 — Application filed
  • 2016-09-07 — Approved for pub - principal register
  • 2016-09-10 — Application filed
  • 2016-09-28 — Notice of publication
  • 2016-10-18 — Published for opposition
  • 2017-01-03 — Registered-principal register
  • 2017-02-02 — Grant of protection created, to be sent to ib
  • 2017-02-24 — Final disposition recorded
  • 2017-02-24 — Final disposition recorded
  • 2017-05-12 — Notification processed by ib
  • 2023-07-14 — Cancelled section 71
  • 2023-07-14 — Final status recorded
  • 2024-03-14 — Total invalidation of reg ext protection created
  • 2025-04-08 — Generic madrid transaction sent to ib
  • 2025-04-08 — Invalidation reviewed - no action required by office
  • 2025-04-08 — Generic madrid transaction created
  • 2025-05-31 — Further decision processed by ib

Owner Information

Novartis AG
CH
Novartis AG
CH
Novartis AG
CH

Correspondent

Novartis Pharma AG, Trademark Department
Postfach
CH-4002 Basel,
SWITZERLAND

Filing Details

Filing Date:
2016-07-06
Status Date:
2023-07-14
Category:
Pharmaceuticals
Filing Year:
2005

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.